Research location
Avellino
AV, Italy
Advertisement
Research activity in Avellino
AV, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 22 trials and 22 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Avellino
21 linked trials · page 1 of 1GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World SettingNCT07583485 · 2024-07-01 · 1 site observation
RECRUITING
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"NCT06871501 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceNCT06070961 · 2024-05-07 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID StudyNCT06835348 · 2023-10-03 · 1 site observation
COMPLETED
BRING-UP 3 Heart FailureNCT06279988 · 2023-09-15 · 1 site observation
UNKNOWN
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC SubjectsNCT03631199 · 2018-12-21 · 1 site observation
TERMINATED
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET DeregulationNCT03911193 · 2018-09-21 · 1 site observation
UNKNOWN
BLITZ Heart FailureNCT03661060 · 2017-03-08 · 1 site observation
COMPLETED
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 1 site observation
COMPLETED
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLCNCT02273375 · 2015-02-24 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14 · 1 site observation
COMPLETED
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)NCT01945775 · 2013-10-14 · 1 site observation
COMPLETED
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and CrizotinibNCT01828112 · 2013-06-28 · 1 site observation
COMPLETED
CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast CancerNCT02918084 · 2013-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung CancerNCT01685138 · 2012-12-20 · 1 site observation
COMPLETED
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and CrizotinibNCT01685060 · 2012-11-26 · 1 site observation
COMPLETED
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung CancerNCT01297491 · 2011-05-01 · 1 site observation
COMPLETED
Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus GemcitabineNCT00753714 · 2008-10-01 · 1 site observation
COMPLETED
LBH Phase II in Small Cell Lung Cancer (SCLC)NCT01222936 · 2008-05-01 · 1 site observation
COMPLETED
LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart FailureNCT00668408 · 2008-05-01 · 1 site observation
UNKNOWN
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.NCT00412022 · 2004-03-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.